|
Characteristics of comparative trials included in the meta-analysis |
||||||||||||
| Reference |
Year |
Type of trial |
Study quality score |
Study population/setting |
Method for the micro-biological diagnosis of pneumonia |
Length of ICU stay (days) |
Duration of mechanical ventilation (days) |
Studied drug/dosage |
Drug administration |
Mode of administration |
ITT |
No. of patients clinically evaluable |
|
|
||||||||||||
| Wood et al. [21] |
2002 |
Double-blind, placebo-controlled RCT |
5 |
Mechanically ventilated for >2 days, trauma patients with >1 risk factor for post-traumatic pneumonia; ICU; USA |
Bronchoalveolar lavage |
19 ± 11 vs 21 ± 12 |
16 ± 11 vs 18 ± 13 |
Ceftazidime: 250 mg every 12 hours |
For 7 days |
Aerosolized |
59 |
20 vs 20 |
| Rouby et al. [19] |
1994 |
Non-randomized clinical trial |
NA |
Mechanically ventilated for >3 days; surgical ICU; France |
Bronchoalveolar lavage |
No data |
Survivors: 18 ± 12 vs 12 ± 14 Non-survivors: 9 ± 5 vs 8 ± 4 |
Colistin: 200,000 units every 3 h |
For 2 weeks |
Endotracheal instillation |
598 |
347 vs 251 |
| Rathgeber et al. [18] |
1993 |
RCT |
2 |
Mechanically ventilated; ICU; Germany |
Bronchial secretions |
No data |
17 vs 13 |
Tobramycin: 80 mg every 6 hours |
Until the time of extubation |
Aerosolized |
69 |
29 vs 40 |
| Lode et al. [17] |
1992 |
Double-blind, placebo-controlled, RCT |
2 |
Mechanically ventilated for >3 days; 5 European ICUs |
No data |
No data |
No data |
Gentamicin: 40 mg every 6 hours |
Until the time of extubation (<14 days) |
Endotracheal instillation |
199 |
85 vs 77 |
| Vogel et al. [20] |
1981 |
Non-randomized, controlled clinical trial |
NA |
Mechanically ventilated for >5 days; medical ICU; Germany |
Tracheal aspirates |
No data |
8.3 vs 7.4 |
Gentamicin: 40 mg every 6 hours |
For 2 weeks |
Endotracheal instillation |
40 |
20 vs 20 |
| Klick et al. [15] |
1975 |
Double-blind, placebo-controlled, non-randomized clinical trial |
NA |
Mechanically ventilated or not; respiratory-surgical ICU; USA |
Sputum; Tracheal aspirates |
5.1 vs 5.3 |
No data |
Polymyxin B: 2.5 mg/kg body weight/day in 6 divided doses |
Throughout the entire ICU stay |
Aerosolized |
744 |
355 vs 337 |
| Klatersky et al. [13] |
1974 |
Placebo-controlled RCT |
3 |
Tracheostomised neurosurgical ICU; Belgium |
Sputum; tracheal aspirates; bronchial secretions |
19.9 vs 14.7 |
NA |
Gentamicin: 80 mg every 8 hours |
Throughout the entire ICU stay |
Endotracheal instillation |
110 |
43 vs 42 |
| Greenfield et al. [11] |
1973 |
RCT |
1 |
Mechanically ventilated or not, high-risk patients; respiratory-surgical ICU; USA |
Sputum |
9.0 (median 6.0) vs 7.6 (median 6.0) |
No data |
Polymyxin B: 2.5 mg/kg body weight/day in 6 divided doses |
Throughout the entire ICU stay |
Aerosolized |
58 |
33 vs 25 |
|
Values are for the group receiving prophylactic antibiotics by the respiratory tract versus (vs) the control group. ICU, intensive care unit; ITT, intention-to-treat; NA, non applicable; RCT, randomized controlled trial. | ||||||||||||
Falagas et al. Critical Care 2006 10:R123 doi:10.1186/cc5032 |
||||||||||||